IQVIA Holdings Inc.
- Jurisdiction
United States - LEI
549300W3R20NM4KQPH86 - ISIN
US46266C1053 (IQV )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€204.87 17.5% undervalued - Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. Read full profile
Fundamentals
- Net revenue
€13.39B - Gross margin
34.2% - EBIT
€1.82B - EBIT margin
13.6% - Net income
€1.06B - Net margin
7.9%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
| N/A | |
|
|
|
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
| Name | Title | Transaction Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Cherofsky Keriann | See Remarks |
|
|
|
|
| Sherbet Eric | See Remarks |
|
|
|
|
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Robert Bresnahan | May 31, 2025 | $1.00K–$15.00K |
| Robert Bresnahan | May 8, 2025 | $15.00K–$50.00K |
| Robert Bresnahan | March 27, 2025 | $1.00K–$15.00K |
| Markwayne Mullin | February 13, 2025 | $15.00K–$50.00K |
| Markwayne Mullin | August 20, 2024 | $15.00K–$50.00K |
Earnings Calls
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Peter Brown |
|
|
|
Buy |
Earnings Calls
Latest earnings call: July 22, 2025 (Q2 2025)